Pathstone Holdings, LLC Exact Sciences Corp Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
A detailed history of Pathstone Holdings, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 16,125 shares of EXAS stock, worth $668,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,125
Previous 10,389
55.21%
Holding current value
$668,058
Previous $449,000
90.65%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
636Shares Held
159MCall Options Held
1.64MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA17.9MShares$742 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA17.8MShares$739 Million0.13% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$518 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$500 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$274 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...